Cite
WILL (When to Induce Labour to Limit risk in pregnancy hypertension): a multicentre randomised controlled trial - adaptations to deliver a timing-of-birth trial during the COVID-19 international pandemic.
MLA
Magee, Laura A., et al. “WILL (When to Induce Labour to Limit Risk in Pregnancy Hypertension): A Multicentre Randomised Controlled Trial - Adaptations to Deliver a Timing-of-Birth Trial during the COVID-19 International Pandemic.” Trials, vol. 23, no. 1, Oct. 2022, pp. 1–10. EBSCOhost, https://doi.org/10.1186/s13063-022-06834-4.
APA
Magee, L. A., Tohill, S., Kirkham, K., Evans, R., Gkini, E., Moakes, C. A., Stubbs, C., Thornton, J., von Dadelszen, P., the WILL Trial Study Group, Brocklehurst, P., Chappell, L., Dorling, J., Green, M., Hardy, P., Hutcheon, J., Moakes, C., Mol, B., Morris, K., & Riley, P. (2022). WILL (When to Induce Labour to Limit risk in pregnancy hypertension): a multicentre randomised controlled trial - adaptations to deliver a timing-of-birth trial during the COVID-19 international pandemic. Trials, 23(1), 1–10. https://doi.org/10.1186/s13063-022-06834-4
Chicago
Magee, Laura A., Sue Tohill, Katie Kirkham, Ruth Evans, Eleni Gkini, Catherine A. Moakes, Clive Stubbs, et al. 2022. “WILL (When to Induce Labour to Limit Risk in Pregnancy Hypertension): A Multicentre Randomised Controlled Trial - Adaptations to Deliver a Timing-of-Birth Trial during the COVID-19 International Pandemic.” Trials 23 (1): 1–10. doi:10.1186/s13063-022-06834-4.